103
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Pseudo–pseudo Meigs' syndrome (PPMS) in chronic lupus peritonitis: a case report with review of literature

ORCID Icon, ORCID Icon, , , , , , & show all
Pages 300-305 | Received 03 Mar 2021, Accepted 07 Apr 2021, Published online: 10 May 2021
 

Abstract

Gastrointestinal involvement in systemic lupus erythematosus (SLE) usually occurs in the form of mesenteric vasculitis, protein-losing enteropathy, intestinal pseudo-obstruction, and pancreatitis. We describe a 23-year-old female, a known case of SLE presented with significant ascites and pleural effusion. Further evaluation showed elevated CA-125 levels without evidence of malignancy. The patient was treated with corticosteroids, hydroxychloroquine, and azathioprine resulting in the resolution of ascites in 2 weeks. The triad of ascites, pleural effusion, and increased CA-125 is known as pseudo-pseudo Meigs' syndrome, which is rarely reported in the literature. Clinicians should be aware of this entity while evaluating an SLE patient with low serum-ascites albumin gradient (SAAG) ascites.

Patient consent

The patient gave their informed written consent prior to their inclusion in this case report.

Ethical approval

Not applicable.

Conflicts of interest

None.

Additional information

Funding

This manuscript has been prepared without third-party contribution nor financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.